News & Trends - MedTech & Diagnostics

New robot-assisted therapy launches in Australia

Health Industry Hub | November 2, 2020 |

MedTech News: A new state-of-the art robotic gait rehabilitation therapy device launched in Australia on World Stroke Day.

The first of its kind equipment is being hailed a revolutionary game changer for over 60,000 Australians who suffer from a Stroke every year, as well as for people living with other neurological disabilities such as brain or spinal cord injury, Multiple Sclerosis, Parkinson’s, Hereditary Spastic Paraplegia, Cerebral Palsy and Functional Neurological Disorder (FND).

The LEXO works by helping to improve walking ability, speed and endurance more effectively through its individually adjustable end-effector gait training robot, combined with dynamic body weight support system. These features facilitate a natural walking pattern, provide sensory feedback and dynamic body weight support to assist with re-training gait. This means that the LEXO enables a more effective return to walking and at a higher quality.

NSW government provided special support for the LEXO to be allowed into Australia from Austria during COVID-19, with leading neurological rehabilitation and disability provider, Advance Rehab Centre in Artarmon, Sydney being the first rehabilitation centre in the world to purchase this device.

Melissa McConaghy, CEO of Advance Rehab Centre and Australian Physiotherapist of the Year 2019, said that during rehabilitation, patients need to be challenged at and beyond their individual capabilities. “Speed, support and gamification can be adjusted on the LEXO® to optimally drive the intensity and engagement of the therapy meaning much more effective results.”

“90% of Stroke survivors have some functional disability, with mobility being the major component. The inability to walk independently detracts from quality of life, individual dignity and leads to higher levels of dependence and possible re-admission to hospital. It can also bring about secondary complications such as Osteoporosis and heart disease,” Ms McConaghy said.

“The use of the robotic gait trainer in rehabilitation for people after Stroke and other neurological issues increases their chance of walking independently at the end of the intervention phase. Patients are motivated to reach their goals with various game-like exercises and can achieve up to five times more practice in the device than traditional over-ground training. Their increased level of activity influences the performance of the task, the gait quality and the speed,” she said.

People in the first three months after a Stroke and those who are not able to walk independently benefit most from the LEXO.

The Cochrane review – the highest standard in evidence-based health care – states that, “people who receive electromechanical-assisted gait training in combination with physiotherapy after Strokes are more likely to achieve independent walking than people who receive gait training without these devices.”

The LEXO allows therapists to focus on the patient and the actual therapy, which enhances staff efficiency and safety, leads to higher training intensity, more treatments per therapist and consistent, superior patient care.

Trent Zimmerman, Member for North Sydney, said the assistance that the LEXO device will provide to patients across NSW and Australia who are learning to walk again after a Stroke, spinal cord injuries and other neurological problems is invaluable.

“I wish Advance Rehab Centre every success with their important work improving patients’ daily skills, health and wellbeing,” Mr Zimmerman said.

The LEXO, only available at Advance Rehab Centre, is backed by a research partnership with Macquarie University.

News & Trends - Pharmaceuticals

Is the government is gearing up to release the long-awaited response to The New Frontier report?

Government’s long-awaited response to The New Frontier report unveiled after two-year wait

Health Industry Hub | December 1, 2023 |

Pharma News: The Albanese Government has tabled its response to the House of Reps inquiry and The New Frontier report […]


News & Trends - Pharmaceuticals

Gilead welcomes HIV Taskforce report and celebrates the 'unsung heroes'

Gilead welcomes HIV Taskforce report and celebrates the ‘unsung heroes’

Health Industry Hub | December 1, 2023 |

Pharma News: On World AIDS Day, the National Association of People with HIV Australia (NAPWHA) and Gilead Sciences Australia have […]


News & Trends - Pharmaceuticals

AbbVie secures PBS listing of first therapy for Crohn's disease in seven years

AbbVie secures PBS listing of first therapy for Crohn’s disease in seven years

Health Industry Hub | December 1, 2023 |

Pharma News: AbbVie’s Rinvoq (upadacitinib), a once-daily tablet, has been officially listed on the Pharmaceutical Benefits Scheme (PBS) for adult […]



New report calls on policy integration of sustainability in medical device and pharmaceutical registrations and funding

New report calls on policy integration of sustainability in medical device and pharmaceutical registrations and funding

Health Industry Hub | November 30, 2023 |

ESG: Increasing pressures from diverse stakeholder groups, spanning policymakers, investors, customers, and employees, have elevated Environmental, Social, and Governance (ESG) […]


This content is copyright protected. Please subscribe to gain access.